EUVIMEDEUVIMED entdecken
Crossref

Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey

Sabine Vogler, Peter Schneider

Generics and Biosimilars Initiative Journal · 15.06.2017 · 6 (2) · 79-88

DOI: 10.5639/gabij.2017.0602.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Generics and Biosimilars Initiative Journal, online erschienen am 15.06.2017. Verfasst von Sabine Vogler und 1 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vogler, S., & Schneider, P. (2017). Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey. Generics and Biosimilars Initiative Journal, 6(2), 79-88. https://doi.org/10.5639/gabij.2017.0602.015

Vancouver

Vogler S, Schneider P. Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey. Generics and Biosimilars Initiative Journal. 2017;6(2):79-88. doi:10.5639/gabij.2017.0602.015

BibTeX
@article{Vogler2017,
  author = {Vogler, Sabine and Schneider, Peter},
  title = {Do pricing and usage-enhancing policies differ between biosimilars and generics? Findings from an international survey},
  journal = {Generics and Biosimilars Initiative Journal},
  year = {2017},
  volume = {6},
  number = {2},
  pages = {79--88},
  doi = {10.5639/gabij.2017.0602.015}
}
Kostenlos starten →